Telmisartan
Micardis
- Dosage form
- Tablet
- Available strengths
- 40 mg, 80 mg
- Drug class
- Angiotensin II receptor blocker (ARB)
- Common brand
- Micardis
Clinical overview. Telmisartan is an angiotensin II receptor blocker (ARB) used to treat high blood pressure and to reduce the risk of stroke or heart attack in high-risk adults who cannot take an ACE inhibitor. It is taken once daily with or without food and is contraindicated in pregnancy due to the risk of serious fetal harm. Key risks include high blood potassium, worsening kidney function, and rare but serious angioedema.
Indication
Common therapeutic uses
- Telmisartan treats mild to moderate high blood pressure (essential hypertension) in adults, either alone or combined with a thiazide diuretic.
- Telmisartan reduces the risk of non-fatal stroke or non-fatal heart attack in adults 55 years or older who are at high risk of cardiovascular events and cannot tolerate an ACE inhibitor.
Pregnancy
Risk assessment and monitoring considerations
Contraindicated in pregnancy. Confirm pregnancy status and discuss alternative therapy with the prescriber before dispensing.
- Telmisartan is contraindicated during pregnancy because drugs that act on the renin-angiotensin system can cause injury or death to the developing fetus.
- If pregnancy is detected, telmisartan should be stopped as soon as possible and, if appropriate, switched to an alternative blood-pressure medication with an established safety record in pregnancy.
- Use in the second and third trimesters has been linked to reduced fetal kidney function, low amniotic fluid, skull bone problems, and newborn kidney failure, low blood pressure, and high potassium.
Breastfeeding
Infant exposure considerations
- It is not known whether telmisartan passes into human breast milk, so a decision should be made to either stop breastfeeding or stop the medication, weighing the importance of treatment to the mother.
Geriatrics
Dosing and tolerability considerations
- No routine dose adjustment is needed for older adults, but some individuals may be more sensitive to its effects.
Pediatrics
Use in children and adolescents
- Telmisartan is not recommended for use in children under 18 because of limited safety and efficacy data.
Dosage & Administration
Practical dosing and administration
- For high blood pressure, the usual dose is 80 mg once daily; a thiazide diuretic may be added if further blood pressure lowering is needed.
- For reducing cardiovascular risk in high-risk patients 55 or older, the dose is 80 mg once daily.
- No initial dose adjustment is required for kidney impairment, though telmisartan levels are markedly reduced in patients on hemodialysis.
- Patients with liver impairment should start at a lower dose of 40 mg daily and be monitored closely.
- The antihypertensive effect begins within 2 weeks and reaches its full effect after about 4 weeks.
- If a dose is missed, the next dose should be taken at the usual time; doses should not be doubled.
Overdose
Recognizing and responding to overdose
If overdose is suspected, seek emergency medical attention immediately or contact your regional Poison Control Centre without delay.
- Limited human data exist on telmisartan overdose; the most common effects reported are low blood pressure and a fast or slow heart rate.
- If symptomatic low blood pressure develops, supportive treatment should be given.
- Telmisartan is not removed by dialysis, so hemodialysis is not useful in overdose management.
Common side effects
Frequently reported tolerability concerns
- Swelling (edema) may occur.
- Palpitations may occur.
- Headache may occur.
- Dizziness may occur.
- Trouble sleeping (insomnia) may occur.
- Abdominal pain, diarrhea, indigestion, nausea, constipation, or gastritis may occur.
- Joint pain, muscle cramps or leg pain, and muscle aches may occur.
- Shortness of breath may occur.
- Skin rash may occur.
- Anxiety or nervousness may occur.
- Chest pain, flu-like symptoms, fatigue, or conjunctivitis may occur.
- Upper respiratory or urinary tract infections may occur.
Serious side effects
Findings that may require urgent assessment
Serious side effects require immediate discussion with the prescriber or emergency care.
- Rare but potentially fatal swelling of the face, lips, tongue, or throat (angioedema) can occur and requires immediate medical attention.
- Fainting (syncope) can occur.
- Kidney function can worsen, including acute kidney injury, particularly in patients dependent on the renin-angiotensin system for kidney blood flow.
- High potassium levels (hyperkalemia) can develop.
- Liver problems, including abnormal liver function tests, can occur.
- Low blood counts, including anemia and low platelets (thrombocytopenia), can occur.
- Severe skin reactions, including drug eruption and toxic skin reactions, can occur.
- Muscle pain, weakness, or breakdown (rhabdomyolysis) has been reported.
- Seek urgent medical attention for swelling of the face or throat, severe dizziness or fainting, or signs of a serious allergic reaction.
Use with caution
Situations requiring closer assessment
- Use with caution in patients who are dehydrated or have low blood volume, since starting therapy can cause a drop in blood pressure.
- Use with caution in patients with narrowing of the aortic or mitral heart valve, or obstructive hypertrophic cardiomyopathy.
- Use with caution in patients with ischemic heart disease or cerebrovascular disease, since an excessive blood pressure drop could trigger a heart attack or stroke.
- Use with caution in patients with kidney artery narrowing (renal artery stenosis) or severe heart failure, since blocking the renin-angiotensin system can worsen kidney function.
- Use with caution in patients with liver impairment, since telmisartan clearance is reduced.
- Use with caution in patients with diabetes, who may have undiagnosed coronary artery disease.
- Use with caution in patients taking potassium-sparing diuretics, potassium supplements, or salt substitutes containing potassium, due to the risk of high potassium.
- Use with caution when driving or operating machinery, since dizziness or fainting can occur.
Contraindications
Situations where therapy may be inappropriate
- Contraindicated in patients hypersensitive to telmisartan or any ingredient in the product.
- Contraindicated during pregnancy.
- Contraindicated during breastfeeding.
- Contraindicated in combination with aliskiren-containing products in patients with diabetes or moderate to severe kidney impairment.
- Contraindicated in patients with the rare hereditary condition fructose intolerance, because the tablets contain sorbitol.
Drug interactions
Clinically relevant combinations
- Combining telmisartan with ACE inhibitors or aliskiren increases the risk of low blood pressure, high potassium, and worsening kidney function, and is contraindicated in patients with diabetes or moderate-to-severe kidney impairment.
- Potassium-sparing diuretics, potassium supplements, and potassium-containing salt substitutes can raise blood potassium levels when combined with telmisartan.
- Telmisartan can raise digoxin blood levels, so digoxin levels should be monitored when starting, adjusting, or stopping telmisartan.
- Starting telmisartan in patients already on diuretics can cause an excessive drop in blood pressure.
- NSAIDs, including acetylsalicylic acid at anti-inflammatory doses and COX-2 inhibitors, combined with telmisartan can increase the risk of kidney failure and high potassium, and may reduce telmisartan's blood-pressure-lowering effect.
- Lithium combined with telmisartan can increase lithium blood levels and toxicity; lithium levels should be monitored.
- Telmisartan may modestly decrease warfarin blood levels, though this has not been shown to significantly change the INR.
- Coadministration with ramipril can raise ramipril blood levels.
Food interactions
Meal-related administration
- Telmisartan can be taken with or without food; while food slightly reduces peak blood levels, this does not meaningfully affect its blood-pressure-lowering effect.
Time of administration
Practical scheduling
- Take telmisartan once daily, preferably at the same time each day such as in the morning, with or without food.
Storage
Product handling
- Store telmisartan tablets at room temperature (15-30°C) and keep them in their blister packaging until immediately before use, since the tablets absorb moisture easily.
Patient take-away
Key counselling points for a quick closing summary
- Telmisartan lowers blood pressure and helps protect the heart and blood vessels in people at high cardiovascular risk.
- Take it exactly as prescribed, at the same time each day, and do not stop without talking to your doctor.
- Tell your doctor right away if you become pregnant, and seek emergency care for facial or throat swelling.
- Keep regular appointments so your blood pressure, kidney function, and blood potassium can be monitored.
References
Source material and product information
For professional reference. Confirm patient-specific decisions against the current approved product monograph and applicable clinical guidance.